Concorde Financial Corp bought a new position in shares of The Procter & Gamble Company (NYSE: PG – Get Rating) during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund bought 334 shares of the company stock, valued at approximately $ 55,000.
Several other institutional investors also recently modified their holdings of the company. OLD Mission Capital LLC acquired a new position in Procter & Gamble in the third quarter valued at approximately $ 349,000. Morgan Stanley lifted its holdings in Procter & Gamble by 5.0% in the second quarter. Morgan Stanley now owns 34,500,719 shares of the company stock valued at $ 4,655,181,000 after acquiring an additional 1,632,893 shares during the last quarter. Keudell Morrison Wealth Management lifted its holdings in Procter & Gamble by 2.4% in the third quarter. Keudell Morrison Wealth Management now owns 9,450 shares of the company stock valued at $ 1,321,000 after acquiring an additional 219 shares during the last quarter. Center for Financial Planning Inc. lifted its holdings in Procter & Gamble by 4.2% in the third quarter. Center for Financial Planning Inc. now owns 20,270 shares of the company stock valued at $ 2,834,000 after acquiring an additional 816 shares during the last quarter. Finally, EagleClaw Capital Managment LLC lifted its holdings in Procter & Gamble by 17.0% in the third quarter. EagleClaw Capital Managment LLC now owns 6,775 shares of the company stock valued at $ 946,000 after acquiring an additional 985 shares during the last quarter. Institutional investors and hedge funds own 63.64% of the company stock.
Shares of NYSE PG opened at $ 132.51 on Thursday. The stock has a market cap of $ 317.93 billion, a P / E ratio of 23.13, a PEG ratio of 4.01 and a beta of 0.40. The company has a current ratio of 0.68, a quick ratio of 0.47 and a debt-to-equity ratio of 0.53. The Procter & Gamble Company has a 12-month low of $ 129.50 and a 12-month high of $ 165.35. The business’s fifty day simple moving average is $ 152.16 and its 200-day simple moving average is $ 154.89.
Procter & Gamble (NYSE: PG – Get Rating) last posted its quarterly earnings results on Wednesday, April 20th. The company reported $ 1.33 earnings per share for the quarter, beating analysts’ consensus estimates of $ 1.28 by $ 0.05. Procter & Gamble had a return on equity of 32.39% and a net margin of 18.33%. The company had revenue of $ 19.38 billion for the quarter, compared to analysts’ expectations of $ 18.69 billion. During the same period last year, the firm earned $ 1.26 earnings per share. Procter & Gamble’s quarterly revenue was up 7.0% on a year-over-year basis. On average, equities analysts forecast that The Procter & Gamble Company will post 5.85 EPS for the current fiscal year.
The firm also recently declared a quarterly dividend, which was paid on Monday, May 16th. Shareholders of record on Friday, April 22nd were paid a $ 0.9133 dividend. The ex-dividend date was Thursday, April 21st. This is a boost from Procter & Gamble’s previous quarterly dividend of $ 0.87. This represents a $ 3.65 dividend on an annualized basis and a yield of 2.76%. Procter & Gamble’s dividend payout ratio (DPR) is currently 63.70%.
In other news, CAO Matthew W. Janzaruk sold 334 shares of Procter & Gamble stock in a transaction dated Tuesday, April 26th. The stock was sold at an average price of $ 162.43, for a total transaction of $ 54,251.62. Following the sale, the chief accounting officer now owns 1,220 shares in the company, valued at $ 198,164.60. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Chairman David S. Taylor sold 60,000 shares of Procter & Gamble stock in a transaction dated Thursday, April 21st. The stock was sold at an average price of $ 164.52, for a total value of $ 9,871,200.00. Following the sale, the chairman now owns 253,933 shares in the company, valued at approximately $ 41,777,057.16. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 108,415 shares of company stock worth $ 17,777,055. 0.51% of the stock is owned by insiders.
PG has been the topic of a number of research reports. Deutsche Bank Aktiengesellschaft decreased their price target on Procter & Gamble from $ 177.00 to $ 171.00 in a research note on Wednesday, June 1st. StockNews.com upgraded Procter & Gamble from a “hold” rating to a “buy” rating in a research note on Wednesday, May 18th. Truist Financial upgraded Procter & Gamble from a “hold” rating to a “buy” rating and upped their price target for the stock from $ 165.00 to $ 175.00 in a research note on Tuesday, March 22nd. Wells Fargo & Company decreased their price target on Procter & Gamble from $ 180.00 to $ 170.00 and set an “overweight” rating on the stock in a research note on Wednesday, June 1st. Finally, The Goldman Sachs Group decreased their price target on Procter & Gamble from $ 179.00 to $ 173.00 in a research note on Tuesday, March 29th. Six analysts have rated the stock with a hold rating and ten have assigned a buy rating to the company stock. According to MarketBeat.com, Procter & Gamble currently has a consensus rating of “Buy” and an average price target of $ 164.27.
Procter & Gamble Profile: (Get Rating)
The Procter & Gamble Company provides branded consumer packaged goods to consumers in North and Latin America, Europe, the Asia Pacific, Greater China, India, the Middle East, and Africa. It operates in five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care.
Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Procter & Gamble Company (NYSE: PG – Get Rating).
Receive News & Ratings for Procter & Gamble Daily: – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Procter & Gamble and related companies with MarketBeat.com’s FREE daily email newsletter.